Rapid CD40-mediated rescue from CD95-induced apoptosis requires TNFR-associated factor-6 and PI3K

European Journal of Immunology

Volumn 36, Issue 9, 2006, Pages 2535-2543

  Benson, Rebecca J ^a   Hostager, Bruce S ^b   Bishop, Gail A ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

Apoptosis; B lymphocyte; Cellular activation; Signal transduction

Indexed keywords

CASPASE 3; CASPASE 8; CD40 ANTIGEN; FAS ANTIGEN; FAS ASSOCIATED DEATH DOMAIN PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 1; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 3; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6;

ANIMAL CELL; APOPTOSIS; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CELL LINE; CELL MUTANT; CONTROLLED STUDY; ENZYME ACTIVATION; GENE TARGETING; HUMORAL IMMUNITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; ANTIGENS, CD40; ANTIGENS, CD95; APOPTOSIS; B-LYMPHOCYTES; CASPASES; CELL LINE; ENZYME ACTIVATION; IMMUNOBLOTTING; IMMUNOPRECIPITATION; LYMPHOCYTE ACTIVATION; MICE; RECEPTORS, TUMOR NECROSIS FACTOR; TNF RECEPTOR-ASSOCIATED FACTOR 1; TNF RECEPTOR-ASSOCIATED FACTOR 2; TNF RECEPTOR-ASSOCIATED FACTOR 3; TNF RECEPTOR-ASSOCIATED FACTOR 6;

EID: 33748859398     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200535483     Document Type: Article

References (52)

1. + T cells. Nature 1995. 376: 181-184.
2. Rathmell, J. C., Townsend, S. E., Xu, J. C., Flavell, R. A. and Goodnow, C. C., Expansion or elimination of B cells in vivo: Dual roles for CD40- and Fas (CD95)-ligands modulated by the B cell antigen receptor. Cell 1996. 87: 319-329.
3. Bishop, G. A. and Hostager, B. S., Signaling by CD40 and its mimics in B cell activation. Immunol. Res. 2001. 24: 97-109.
4. Bishop, G. A. and Hostager, B. S., B lymphocyte activation by contact-mediated interactions with T lymphocytes. Curr. Opin. Irnmunol. 2001. 13: 278-285.
5. Bishop, G. A. and Hostager, B. S., Molecular mechanisms of CD40 signaling. Arch. Immunol. Ther. Exp. 2001. 49: 129-137
6. Schattner, E. J., Elkon, K B., Yoo, D. H., Tumang, J., Krammer, P. H., Crow, M. K. and Friedman, S. M., CD40 ligation induces APO-1/Fas expression on human B lymphocytes and facilitates apoptosis through the APO-1/Fas pathway. J. Exp. Med. 1995. 182: 1557-1565.
7. Fisher, G. H., Rosenberg, F. J., Straus, S. E., Dale, J. K., Middleton, L. A., Lin, A. Y., Strober, W. et al., Dominant interfering Fas gene mutations impair apoptosis in a human autoimmume lymphoproliferative syndrome. Cell 1995. 81: 935-946.
8. Sneller, M. C., Straus, S. E., Jaffe, E. S., Jaffe, J. S., Fleisher, T. A., Stetler-Stevenson, M. and Strober, W., A novel lymphoproliferative/ autoimmune syndrome resembling murine lpr/gld disease. J. Clin. Invest. 1992. 90: 334-341.
9. Watanabe-Fukunaga, R., Brannan, C. I., Copeland, N. G., Jenkins, N. A. and Nagata, S., Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 1992. 356: 314-317.
10. Fukuyama, H., Adachi, M., Suematsu, S., Miwa, K., Suda, T., Yoshida, N. and Nagata, S., Transgenic expression of Fas in T cells blocks lymphoproliferation but not autoimmune disease in MRL-lpr mice. J. Immunol. 1998. 160: 3805-3811.
11. Fukuyama, H., Adachi, M., Suematsu, S., Miwa, K., Suda, T., Yoshida, N. and Nagata, S., Requirement of Fas expression in B cells for tolerance induction. Eur. J. Immunol. 2002. 32: 223-230.
12. Kischkel, F. C., Hellbardt, S., Behrmann, I., Germer, M., Pawlita, M., Krammer, P. H. and Peter, M. E., Cytotoxicity-dependent APO-1 (Fas/ CD95)-associated proteins forma DISC with the receptor. EMBO J. 1995. 14: 5579-5588.
13. Chinnaiyan, A. M., O'Rourke, K., Tewari, m. and Dixit, V. M., FADD, a novel death domairi-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 1995. 81: 505-512.
14. Muzio, M., Chinnaiyan, A. M., Kischkel, F. C., O'Rourke, K., Shevchenko, A., Ni, J., Scaffidi, C. et al., FLICE, a novel FADD-homologous ICE/ CED-3-like protease, is recruited to the CD95 (Fas/APO-1) DISC. Cell 1996. 85: 817-827
15. Boldin, M. P., Goncharov, T. M., Goltsev, Y. V. and Wallach, D., Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/ APO-1- and TNF receptor-induced cell death. Cell 1996. 85: 803-815.
16. Salvesen, G. S. and Dixit, V. M., Caspase activation: The induced-proximity model. Proc. Natl. Acad. Sci. USA 1999. 96: 10964-10967
17. Wang, C. Y., Mayo, M. W., Korneluk, R. G., Goeddel, D. V. and Baldwin, A. S., Jr., NF-κB antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 1998. 281: 1680-1683.
18. Micheau, O., Lens, S., Gaide, O., Alevizopoulos, K. and Tschopp, J., NF-κB signals induce the expression of c-FLIP. Mol. Cell. Biol. 2001. 21: 5299-5305.
19. Lee, H. H., Dadgostar, H., Cheng, Q., Shu, J. and Cheng, G., NF-κB-mediated up-regulation of Bcl-x and Bfl-1/A1 is required for CD40 survival signaling in B lymphocytes. Proc. Natl. Acad. Sci. USA 1999. 96: 9136-9141.
20. Zazzeroni, F., Papa, S., Algeciras-Schimnich, A., Alvarez, K., Melis, T., Bubici, C., Majewski, N. et al., Gadd45beta mediates the protective effects of CD40 costimulation against Fas-induced apoptosis. Blood 2003. 102: 3270-3279.
21. Arch, R. H., Gedrich, R. W. and Thompson, C. B., TRAFs - a family of adapter proteins that regulates life and death. Genes Dev. 1998. 12: 2821-2830.
22. Bishop, G. A., The multifaceted roles of TRAFs in the regulation of B-cell function. Nat. Rev. Immunol. 2004. 4: 775-786.
23. Jalukar, S. V., Hostager, B. S. and Bishop, G. A., Characterization of the roles of TNF receptor-associated factor 6 in CD40-mediated B lymphocyte effector functions. J. Immunol. 2000. 164: 623-630.
24. Hostager, B. S., Haxhinasto, S. A., Rowland, S. L. and Bishop, G. A., TRAF2-deficient B lymphocytes reveal novel roles for TRAF2 in CD40 signaling. J. Biol. Chem. 2003. 278: 45382-45390.
25. Catlett, I. M. and Bishop, G. A., Cutting edge: A novel mechanism for rescue of B cells from CD95/Fas-mediated apoptosis. J. Immunol. 1999. 163: 2378-2381.
26. Catlett, I. M., Xie, P., Hostager, B. S. and Bishop, G. A., Signaling through MHC class II molecules blocks CD95-induced apoptosis. J. Immunol. 2001. 166: 6019-6024.
27. Xie, P., Hostager, B. S. and Bishop, G. A., Requirement for TRAF3 in signaling by LMP1 but not CD40 in B lymphocytes. J. Exp. Med. 2004. 199: 661-671.
28. Schauer, S. L., Wang, Z., Sonenshein, G. E. and Rothstein, T. L., Maintenance of NF-κB/Re1 and c-myc expression during CD40 ligand rescue of WEHI 231 early B cells from receptor-mediated apoptosis through modulation of IκB proteins. J. Immunol. 1996. 157: 81-86.
29. Schauer, S. L., Bellas, R. E. and Sonenshein, G. E., Dominant signals leading to inhibitor κB protein degradation mediate CD40 ligand rescue of WEHI 231 immature B cells from receptor-mediated apoptosis. J. Immunol. 1998. 160: 4398-4405.
30. Zarnegar, B., Unique CD40-mediated biological program in B cell activation requires both type 1 and type 2 NF-κB activation pathways. Proc. Natl. Acad. Sci. USA 2004. 101: 8108-8113.
31. Munroe, M. E. and Bishop, G. A., Role of tumor necrosis factor (TNF) receptor-associated factor 2 (TRAF2) in distinct and overlapping CD40 and TNF receptor 2/CD120b-mediated B lymphocyte activation. J. Biol. Chem. 2004. 279: 53222-53231.
32. Hsing, Y. and Bishop, G. A., Requirement for NF-κB activation by a distinct subset of CD40-mediated effector functions in B lymphocytes. J. Immunol. 1999. 162: 2804-2811.
33. Gerondakis, S. and Strasser, A., The role of Rel/NF-kappaB transcription factors in B lymphocyte survival. Semin. Immunol. 2003. 15: 159-166.
34. Illera, V., Perandones, C., Stunz, L., Mower, D., Jr. and Ashman, R., Apoptosis in splenic B lymphocytes. Regulation by protein kinase C and IL-4. J. Immunol. 1993. 151: 2965-2973.
35. Hostager, B. S., Hsing, Y., Harms, D. E. and Bishop, G. A., Different CD40-mediated signaling events require distinct CD40 structural features. J. Immunol. 1996. 157: 1047-1053.
36. Hsing, Y., Hostager, B. S. and Bishop, G. A., Characterization of CD40 signaling determinants regulating NF-κB activation in B lymphocytes. J. Immunol. 1997. 159: 4898-4906.
37. Haxhinasto, S. A., Hostager, B. S. and Bishop, G. A., Molecular mechanisms of synergy between CD40 and the BCR: Role for TRAF2 in receptor interaction. J. Immunol. 2002. 169: 1145-1149.
38. Wong, B. R., Besser, D., Kim, N., Arron, J. R., Vologodskaia, M., Hanafusa, H. and Choi, Y., TRANCE, a TNF family member, activates Akt,/ PKB through a signaling complex involving TRAF6 and c-Src. Mol. Cell 1999. 4: 1041-1049.
39. Arron, J. R., Vologodskaia, M., Wong, B. R., Naramura, M., Kim, N., Gu, H. and Choi, Y., A positive regulatory role for Cbl family proteins in TRANCE and CD40L-mediated Akt activation. J. Biol. Chem. 2001. 276: 30011-30017.
40. Vlahos, C. J., Matter, W. F., Hui, K. Y. and Brown, R. F., A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzo-pyran-4-one (LY294002). J. Biol. Chem. 1994. 269: 5241-5248.
41. Wang, J., Lobito, A. A., Shen, F., Hornung, F., Winoto, A. and Lenardo, M. J., Inhibition of Fas-mediated apoptosis by the B cell antigen receptor through c-FLIP. Eur. J. Immunol. 2000. 30: 155-163.
42. Tumang, J. R., Negm, R. S., Solt, L. A., Schneider, T. J., Colarusso, T. P., Hastings, W. D., Woodland, R. T. et al., BCR engagement induces Fas resistance in primary B cells in the absence of functional Bruton's tyrosine kinase. J. Immunol. 2002. 168: 2712-2719.
43. Hinshaw, J. A., Mueller, C. M., Scott, D. W. and Williams, M. S., B cell receptor signaling mediates immediate protection from Fas-induced apoptosis upstream of caspase activation through an atypical protein kinase C isozyme and de novo protein synthesis. Eur. J. Immunol. 2003. 33: 2490-2500.
44. Cleary, A. M., Fortune, S. M., Yellin, M. J., Chess, L. and Lederman, S., Opposing roles of CD95 (Fas/APO-1) and CD40 in the death and rescue of human low density tonsillar B cells. J. Immunol. 1995. 155: 3329-3337.
45. Koopman, G., Keehnen, R. M., Lindhout, E., Zhou, D. F., de Groot C. and Pals, S. T., Germinal center B cells rescued from apoptosis by CD40 ligation or attachment to follicular dendritic cells, but not by engagement of surface immunoglobulin or adhesion receptors, become resistant to CD9S-induced apoptosis. Eur. J. Immunol. 1997. 27: 1-7.
46. Wu, H. and Arron, J. R., TRAF6, a molecular bridge spanning adaptive immunity, innate immunity and osteoinummology. Bioessays 2003. 25: 1096-1105.
47. Song, G., Ouyang, G. and Bao, S., The activation of Akt/PKB signaling pathway and cell survival. J. Cell. Mol. Med. 2005. 9: 59-71.
48. Kim, K. J., Kanellopoulos-Langevin, C., Merwin, R. M., Sachs, D. H. and Asofsky, R., Establishment and characterization of BALB/c lymphoma lines with B cell properties. J. Immunol. 1979. 122: 549-554.
49. + B cells by clonal T cells and antigen. Proc. Natl. Acad. Sci. USA 1986. 83: 7410-7414.
50. Bishop, G. A., Warren, W. D. and Berton, M. T., Signaling via major histocompatibility complex class II molecules and antigen receptors enhances the B cell response to gp39/CD40 ligand. Eur. J. Immunol. 1995. 25: 1230-1238.
51. Bishop, G. A., Haxhinasto, S. A., Stunz, L. L. and Hostager, B. S., Antigen-specific B-lymphocyte activation. Crit. Rev. Immunol. 2003. 23: 149-197.
52. Hostager, B. S., Catlett, I. M. and Bishop, G. A., Recruitment of CD40 and TRAFs 2 and 3 to membrane microdomains during CD40 signaling. J. Biol. Chem. 2000. 275: 15392-15398.